Majority of patients not asked for consent before being switched to a biosimilar, survey finds

17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...

Read more →

Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

NICE recommends Skyrizi, Forxiga

15 July 2019 - NICE has recommended two new drugs on the NHS, AbbVie’s Skyrizi (risankizumab) and AstraZeneca’s Forxiga (dapagliflozin) ...

Read more →

NICE recommends innovative treatment for type 1 diabetes

12 July 2019 - It’s estimated that around 90,000 people could be eligible for treatment with dapagliflozin. ...

Read more →

Amazon’s Alexa to offer NHS health care advice

10 July 2019 - The UK Government has announced that the NHS has plans to collaborate with Amazon to provide ...

Read more →

'Amazing' gene-silencing drugs reach NHS

9 July 2019 - A new form of medicine called "gene-silencing" has been approved for use by the NHS in ...

Read more →

NICE Onpattro approval puts Alnylam back in hATTR running

 9 July 2019 - NICE has recommended the use of Alynylam’s Onpattro (patisiran), after issuing a preliminary ‘no’, back in ...

Read more →

Cystic fibrosis scandal: Drugs boss tells boy, 9, he wants NHS deal to save lives

8 July 2019 - The millionaire boss of a US drugs firm has penned a personal letter to a boy with ...

Read more →

NHS England scraps 7 more drugs on prescription

8 July 2019 - NHS England has issued a new guidance scrapping seven medicines from its prescriptions list, estimating to save ...

Read more →

AstraZeneca boss calls for NHS drug approval shake-up

5 July 2019 - AstraZeneca has called for a wholesale review of the way new drugs are paid for in ...

Read more →

AZ appeals against NICE rejection of Tagrisso in untreated lung cancer

5 July 2019 - AstraZeneca is appealing against NICE’s decision not to recommend funding for its lung cancer drug Tagrisso ...

Read more →

Device for preventing and relieving pain of cluster headaches approved by NICE in draft guidance

5 July 2019 - A handheld device that delivers a small electric current has been recommended by NICE for the prevention ...

Read more →

Life-extending lung cancer treatment recommended for use on the NHS

5 July 2019 - Dacomitinib has been recommended as a first-line treatment option for people with a type of non-small-cell lung ...

Read more →

Spinraza access agreement extended

3 July 2019 - More children with the rare genetic disorder spinal muscular atrophy can now be treated with Spinraza after ...

Read more →

Immediately after EU nod, England’s NHS funds Sanofi skin cancer drug

2 July 2019 - Patients in England will be among those who are first to benefit from Sanofi and Regeneron’s ...

Read more →